Craig Collard

Craig Collard

Chief Executive Officer at HERON THERAPEUTICS, INC.

Net worth: 2 M $ as of 2024-03-30

58 year
Health Technology
Health Services
Consumer Services

Network origin in Craig Collard first degree

EntityEntity typeIndustry
Public Company Agricultural Commodities/Milling 32
29
Non-Profit Organization Medical/Nursing Services 29
Extinct Biotechnology 28
Subsidiary Pharmaceuticals: Major 24
Public Company Biotechnology 20
Subsidiary Pharmaceuticals: Major 19
Subsidiary Pharmaceuticals: Major 16
10
Extinct Pharmaceuticals: Major 10
10
Private Company Pharmaceuticals: Major 10
2
Subsidiary Pharmaceuticals: Major 2
DJ Pharma, Inc.
2
Extinct 2

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Craig Collard via their personal network

CompanySectorRelated peopleMain position
ABBOTT LABORATORIES Medical Specialties

Andrew Allen

Susan Rodriguez

Corporate Officer/Principal

Sales & Marketing

Pharmaceuticals: Major

John W. Poyhonen

Barry Quart

Sales & Marketing

Chief Tech/Sci/R&D Officer

Biotechnology

Stephen Dilly

Barbara Klencke

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

ELI LILLY AND COMPANY Pharmaceuticals: Major

Kimberly Manhard

Michael Heffernan

Corporate Officer/Principal

Corporate Officer/Principal

MERCK & CO., INC. Pharmaceuticals: Major

Lars Kåre Viksmoen

William Polvino

Graham Lumsden

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

PFIZER, INC. Pharmaceuticals: Major

John W. Poyhonen

Barry Quart

Sales & Marketing

Corporate Officer/Principal

VERTEX PHARMACEUTICALS INCORPORATED Pharmaceuticals: Major

Eric Olson

Dodzie Sogah

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Medical Specialties

Mary Christina Thomson

Stephen Dilly

General Counsel

Director/Board Member

ACADIA PHARMACEUTICALS INC. Pharmaceuticals: Major

Kimberly Manhard

Stephen Davis

Corporate Officer/Principal

Chief Executive Officer

Pharmaceuticals: Major

William Polvino

President

Pharmaceuticals: Major

Susan Rodriguez

Jason Wild

Corporate Officer/Principal

Chairman

Investment Managers

Andrew Sinclair

Corporate Officer/Principal

College/University

David Szekeres

Kara DioGuardi

Graduate Degree

Undergraduate Degree

College/University

Dodzie Sogah

Kate O’Donnell

Graduate Degree

Undergraduate Degree

University of Pennsylvania College/University

Susan Rodriguez

Rajin K. Ahuja

Graduate Degree

Masters Business Admin

Investment Managers

Andrew Sinclair

Private Equity Analyst

Miscellaneous Commercial Services

Andrew Sinclair

David J. Price

Corporate Officer/Principal

Corporate Officer/Principal

Boston College College/University

William Polvino

Undergraduate Degree

Creighton University College/University

William Forbes

Teresa Elder

Doctorate Degree

Undergraduate Degree

University of California, Berkeley College/University

Michael L. Beatty

Thomas B. Ottoboni

Mona Ashiya

Undergraduate Degree

Doctorate Degree

Undergraduate Degree

University of Connecticut College/University

Michael Heffernan

Christopher George Codeanne

Undergraduate Degree

Masters Business Admin

University of Florida College/University

Kimberly Manhard

Lynn Gefen

Undergraduate Degree

Undergraduate Degree

University of Iowa College/University

Gregory Myers

Laura Shawver

Andrea N. Flynn

Undergraduate Degree

Undergraduate Degree

Doctorate Degree

College/University

Eric Olson

Adam Morgan

Undergraduate Degree

Undergraduate Degree

Pharmaceuticals: Major

Susan Rodriguez

Richard Daly

Corporate Officer/Principal

Corporate Officer/Principal

Pharmaceuticals: Major

Robert E. Pelzer

John D. Weinberg

General Counsel

Corporate Officer/Principal

Investment Banks/Brokers

Andrew Sinclair

Analyst-Equity

VERONA PHARMA PLC Pharmaceuticals: Major

Andrew Sinclair

Director/Board Member

Miscellaneous Commercial Services

Alastair Stuart McEwan

Christopher George Codeanne

Director/Board Member

Director of Finance/CFO

Pharmaceuticals: Major

John W. Poyhonen

Kimberly Manhard

Barry Quart

Stephen Davis

Craig Johnson

Christian Waage

Chris Storgard

Lisa Peraza

Director/Board Member

Chief Operating Officer

Founder

Chief Operating Officer

Director/Board Member

General Counsel

Chief Tech/Sci/R&D Officer

Director/Board Member

King's College London College/University

Andrew Sinclair

Ben Atkins

Undergraduate Degree

Undergraduate Degree

Medical Specialties

Mette Agger

Director/Board Member

Pharmaceuticals: Major

Chenyqua Michele Baldwin

Steven M. Lutz

Director of Finance/CFO

Corporate Officer/Principal

Glaxo, Inc.

William Forbes

Indu Parikh

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

AUSPEX PHARMACEUTICALS INC Pharmaceuticals: Major

Gaurav Aggarwal

John C. Arthur

Director/Board Member

Corporate Officer/Principal

Pharmaceuticals: Major

William Polvino

Chief Executive Officer

The University of North Carolina at Charlotte College/University

Kennedy Clarke O'Herron

Walker A. Long

Chenyqua Michele Baldwin

Graduate Degree

Doctorate Degree

Graduate Degree

TREVI THERAPEUTICS, INC. Biotechnology

William Forbes

Michael Heffernan

Mette Agger

Corporate Officer/Principal

Director/Board Member

Director/Board Member

Harvard Business School College/University

John Weinberg

Robert Niehaus

Kate O’Donnell

Masters Business Admin

Masters Business Admin

Masters Business Admin

Pharmaceuticals: Major

William Polvino

Chief Executive Officer

Packaged Software

Mette Agger

Director/Board Member

Pharmaceuticals: Major

William Polvino

Director/Board Member

LEXEO THERAPEUTICS, INC. Biotechnology

Mette Agger

Director/Board Member

SAB BIOTHERAPEUTICS, INC. Biotechnology

William Polvino

Director/Board Member

Statistics

International

United States 42
United Kingdom 7
Canada 3
Denmark 2

Sectoral

Health Technology 30
Consumer Services 14
Finance 5
Commercial Services 3
Technology Services 2

Operational

Director/Board Member 330
Corporate Officer/Principal 154
Independent Dir/Board Member 93
Chief Executive Officer 74
Chairman 68
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW